» Articles » PMID: 34050709

Setd5 is Required in Cardiopharyngeal Mesoderm for Heart Development and Its Haploinsufficiency is Associated with Outflow Tract Defects in Mouse

Overview
Journal Genesis
Date 2021 May 29
PMID 34050709
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital heart defects are a feature of several genetic haploinsufficiency syndromes, often involving transcriptional regulators. One property of haploinsufficient genes is their propensity for network interactions at the gene or protein level. In this article we took advantage of an online dataset of high throughput screening of mutations that are embryonic lethal in mice. Our aim was to identify new genes where the loss of function caused cardiovascular phenotypes resembling the 22q11.2 deletion syndrome models, that is, heterozygous and homozygous loss of Tbx1. One gene with a potentially haploinsufficient phenotype was identified, Setd5, thought to be involved in chromatin modification. We found murine Setd5 haploinsufficiency to be associated with double outlet right ventricle and perimembranous ventricular septal defect, although no genetic interaction with Tbx1 was detected. Conditional mutagenesis revealed that Setd5 was required in cardiopharyngeal mesoderm for progression of the heart tube through the ballooning stage to create a four-chambered heart.

Citing Articles

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart.

Ma X, Conley S, Kosicki M, Bredikhin D, Cui R, Tran S medRxiv. 2024; .

PMID: 39606363 PMC: 11601760. DOI: 10.1101/2024.11.20.24317557.


Defining Biological and Biochemical Functions of Noncanonical SET Domain Proteins.

Sun W, Justice I, Green E J Mol Biol. 2023; 436(7):168318.

PMID: 37863247 PMC: 10957327. DOI: 10.1016/j.jmb.2023.168318.


Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.

Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B MedComm (2020). 2023; 4(3):e261.

PMID: 37143582 PMC: 10152985. DOI: 10.1002/mco2.261.


Structure, activity and function of the lysine methyltransferase SETD5.

Li M, Hou Y, Zhang Z, Zhang B, Huang T, Sun A Front Endocrinol (Lausanne). 2023; 14:1089527.

PMID: 36875494 PMC: 9982096. DOI: 10.3389/fendo.2023.1089527.


Neurobehavioral characteristics of mice with mutations as models of IDD23 and KBG syndromes.

Nakagawa T, Hattori S, Hosoi T, Nakayama K Front Genet. 2023; 13:1022339.

PMID: 36685966 PMC: 9846138. DOI: 10.3389/fgene.2022.1022339.


References
1.
Szczaluba K, Brzezinska M, Kot J, Rydzanicz M, Walczak A, Stawinski P . SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression. Am J Med Genet A. 2016; 170(9):2322-7. DOI: 10.1002/ajmg.a.37832. View

2.
Christoffels V, Habets P, Franco D, Campione M, de Jong F, Lamers W . Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol. 2000; 223(2):266-78. DOI: 10.1006/dbio.2000.9753. View

3.
Pinard A, Guey S, Guo D, Cecchi A, Kharas N, Wallace S . The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2019; 22(2):427-431. PMC: 7673309. DOI: 10.1038/s41436-019-0639-2. View

4.
Huynh T, Chen L, Terrell P, Baldini A . A fate map of Tbx1 expressing cells reveals heterogeneity in the second cardiac field. Genesis. 2007; 45(7):470-5. DOI: 10.1002/dvg.20317. View

5.
Lin C, Lin C, Chen C, Zhou B, Chang C . Partitioning the heart: mechanisms of cardiac septation and valve development. Development. 2012; 139(18):3277-99. PMC: 3424040. DOI: 10.1242/dev.063495. View